1. Atezolizumab addition to platinum doublet: evaluating survival outcomes for patients with extensive disease small cell lung cancer
   Sousuke Kubo et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
2. Stage IV renal cell carcinoma achieves pathologic complete response after two ipilimumab plus nivolumab courses despite severe immune-related adverse events: a case report
   Ryo Takada et al, 2024, Journal of Pharmaceutical Health Care and Sciences CrossRef